Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-26-015827
Filing Date
2026-04-21
Accepted
2026-04-21 10:53:38
Documents
1

Document Format Files

Seq Description Document Type Size
1 DEFA14A ef20071024_defa14a.htm DEFA14A 30966
  Complete submission text file 0001140361-26-015827.txt   32080
Mailing Address 1500 BROADWAY SUITE 1401 NEW YORK NY 10036
Business Address 1500 BROADWAY SUITE 1401 NEW YORK NY 10036 332-208-6102
Nuvation Bio Inc. (Filer) CIK: 0001811063 (see all company filings)

EIN.: 850862255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39351 | Film No.: 26877218
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)